These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23080516)

  • 1. Inability of mutant transthyretin V30M to cross the blood-eye barrier.
    Beirão JM; Moreira LV; Lacerda PC; Vitorino RP; Beirão IB; Torres PA; Costa PP
    Transplantation; 2012 Oct; 94(8):e54-6. PubMed ID: 23080516
    [No Abstract]   [Full Text] [Related]  

  • 2. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
    Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
    Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined liver-kidney transplantation in familial amyloidotic polyneuropathy TTR V30M: nephrological assessment.
    Lobato L; Beirão I; Seca R; Pessegueiro H; Rocha MJ; Queiroz J; Gomes M; Henriques AC; Teixeira M; Almeida R
    Amyloid; 2011 Jun; 18 Suppl 1():190-2. PubMed ID: 21838483
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of MALDI-TOF Mass Spectrometry to Assay the Transthyretin V30M Mutation in Serum From a Liver Transplant Donor: A Case Report.
    Lacerda PC; Moreira L; Vitorino R; Costa PP
    Transplantation; 2015 May; 99(5):e33-4. PubMed ID: 25943235
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver transplantation and anemia in familial amyloidosis ATTR V30M.
    Beirão I; Lobato L; Costa PM; Fonseca I; Silva M; Bravo F; Cabrita A; Porto G
    Amyloid; 2007 Mar; 14(1):33-7. PubMed ID: 17453623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation in transthyretin amyloidoses. When the neurological benefit outweighs the risk.
    Mascalchi M; Salvi F
    Neurol Sci; 2006 Nov; 27(5):297-8. PubMed ID: 17122935
    [No Abstract]   [Full Text] [Related]  

  • 7. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
    Berg I; Thor S; Hammarström P
    Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticipation of presbyopia in Portuguese familial amyloidosis ATTR V30M.
    Beirão M; Matos E; Beirâo I; Costa PP; Torres P
    Amyloid; 2011 Sep; 18(3):92-7. PubMed ID: 21591979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor outcome after liver transplantation for transthyretin amyloid neuropathy in a family with an Ala36Pro transthyretin mutation: case report.
    Muller KR; Padbury R; Jeffrey GP; Poplawski NK; Thompson P; Tonkin A; Harley HA
    Liver Transpl; 2010 Apr; 16(4):470-3. PubMed ID: 20373457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
    Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S
    Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial amyloid polyneuropathy and liver transplantation.
    Monteiro E; Freire A; Barroso E
    J Hepatol; 2004 Aug; 41(2):188-94. PubMed ID: 15288465
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.
    Lladó L; Baliellas C; Casasnovas C; Ferrer I; Fabregat J; Ramos E; Castellote J; Torras J; Xiol X; Rafecas A
    Liver Transpl; 2010 Dec; 16(12):1386-92. PubMed ID: 21117248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aboard transthyretin: From transport to cleavage.
    Liz MA; Mar FM; Franquinho F; Sousa MM
    IUBMB Life; 2010 Jun; 62(6):429-35. PubMed ID: 20503435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidly Progressive Transthyretin-Mediated Amyloidosis in a Domino Liver Transplant Recipient of a Ser23Asn Donor.
    Dixit N; Castano A; Farr MJ; Traub R; Lentzsch S; Brown RS; Maurer MS; Brannagan TH
    J Clin Neuromuscul Dis; 2016 Mar; 17(3):142-5. PubMed ID: 26905915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transgenic rat with the human ATTR V30M: a novel tool for analyses of ATTR metabolisms.
    Ueda M; Ando Y; Hakamata Y; Nakamura M; Yamashita T; Obayashi K; Himeno S; Inoue S; Sato Y; Kaneko T; Takamune N; Misumi S; Shoji S; Uchino M; Kobayashi E
    Biochem Biophys Res Commun; 2007 Jan; 352(2):299-304. PubMed ID: 17126291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid turnover after liver transplantation in FAP.
    Obayashi K; Ueda M; Jono H; Yamashita T; Yazaki M; Kametani F; Ohya Y; Inomata Y; Ikeda S; Ando Y
    Amyloid; 2011 Jun; 18 Suppl 1():187-9. PubMed ID: 21838482
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term quantitative evaluation of liver transplantation in familial amyloid polyneuropathy (Portuguese V30M).
    de Carvalho M; Conceição I; Bentes C; Luís ML
    Amyloid; 2002 Jun; 9(2):126-33. PubMed ID: 12440485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
    Ikeda K; Kano O; Ito H; Kawase Y; Iwamoto K; Sato R; Sekine T; Nagata R; Nakamura Y; Hirayama T; Iwasaki Y
    Neurology; 2008 Apr; 70(17):1576; author reply 1576-7. PubMed ID: 18427077
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitreal deposits in Val71Ala transthyretin amyloidosis.
    Suan D; Booth DR; Kennedy IH; Downie J; Earls P; Gottlieb D; Stewart GJ; Lin MW
    Intern Med J; 2012 Jan; 42(1):106-8. PubMed ID: 22276564
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical characterization of vitreous amyloid formed after liver transplantation.
    Liepnieks JJ; Phan AD; Wise RJ; Hrisomalos FN; Benson MD
    Amyloid; 2016 Jun; 23(2):136-7. PubMed ID: 27043487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.